P9 Coronary artery calcification on thoracic CT is associated with pulmonary hypertension and is an independent predictor of mortality in systemic sclerosis. (21st September 2022)
- Record Type:
- Journal Article
- Title:
- P9 Coronary artery calcification on thoracic CT is associated with pulmonary hypertension and is an independent predictor of mortality in systemic sclerosis. (21st September 2022)
- Main Title:
- P9 Coronary artery calcification on thoracic CT is associated with pulmonary hypertension and is an independent predictor of mortality in systemic sclerosis
- Authors:
- Rossdale, Jennifer
Graby, John
Charters, Pia
Burnett, Tim
Harris, Maredudd
Jones, Calum
Greenish, Davyd
Bartlett, Jessica
Gilroy, Andrew
Sanghera, Jamie
Robinson, Graham
Pauling, John D
Skeoch, Sarah
Flower, Victoria
Ross, Rob Mackenzie
Suntharalingam, Jay
Rodrigues, Jonathan CL - Abstract:
- Abstract : Objective: Coronary artery calcification (CAC) on thoracic computed tomography (CT) is a known biomarker of coronary artery disease and mortality. Systemic Sclerosis (SSc) is a pro-inflammatory condition; microvascular inflammation is increasingly hypothesised to drive pulmonary hypertension (PH) in SSc. Inflammation is also a driver of CAD. We hypothesised that CAC would be prevalent and associated with mortality in SSc. Methods: Retrospective analysis of 262 CTs in SSc patients from a prospectively maintained clinical database at a tertiary Rheumatology/PH service March 2007-March 2021 (mean age 65±12, 14% male). 86/262 (33%) had interstitial lung disease (ILD), 128/262 (49%) had PH. CTs were re-reviewed for CAC; severity was graded by experienced readers using a four-point scale per vessel and summed for total CAC score (CACS). Results: CAC was present in 152/265 (57%). All-cause mortality occurred in 65/262 (25%) patients over mean 5±3 years follow-up. Presence of CAC was associated with >2 times risk of death (Hazard ratio [HR] 2.41; 95% CI 1.3–4.5; p=0.006), correcting for age and gender. PH was predictive of mortality (HR 3.6, 95%CI 1.4–9.3, p=0.007), corrected for age and gender; ILD was not (HR 1.3, 95% CI 0.8–2.2, p=0.34). PH was significantly associated with CAC (X 2 =7.7, p=0.009). In contrast, ILD had no significant association with CAC (X 2 =0.57, p=0.81). Conclusion: CAC is common in SSc and is associated with PH. PH and CAC are predictors ofAbstract : Objective: Coronary artery calcification (CAC) on thoracic computed tomography (CT) is a known biomarker of coronary artery disease and mortality. Systemic Sclerosis (SSc) is a pro-inflammatory condition; microvascular inflammation is increasingly hypothesised to drive pulmonary hypertension (PH) in SSc. Inflammation is also a driver of CAD. We hypothesised that CAC would be prevalent and associated with mortality in SSc. Methods: Retrospective analysis of 262 CTs in SSc patients from a prospectively maintained clinical database at a tertiary Rheumatology/PH service March 2007-March 2021 (mean age 65±12, 14% male). 86/262 (33%) had interstitial lung disease (ILD), 128/262 (49%) had PH. CTs were re-reviewed for CAC; severity was graded by experienced readers using a four-point scale per vessel and summed for total CAC score (CACS). Results: CAC was present in 152/265 (57%). All-cause mortality occurred in 65/262 (25%) patients over mean 5±3 years follow-up. Presence of CAC was associated with >2 times risk of death (Hazard ratio [HR] 2.41; 95% CI 1.3–4.5; p=0.006), correcting for age and gender. PH was predictive of mortality (HR 3.6, 95%CI 1.4–9.3, p=0.007), corrected for age and gender; ILD was not (HR 1.3, 95% CI 0.8–2.2, p=0.34). PH was significantly associated with CAC (X 2 =7.7, p=0.009). In contrast, ILD had no significant association with CAC (X 2 =0.57, p=0.81). Conclusion: CAC is common in SSc and is associated with PH. PH and CAC are predictors of mortality in SSc and both have a hypothesised pro-inflammatory driver. Further validation is required to assess the potential role for anti-inflammatory therapies. … (more)
- Is Part Of:
- Heart. Volume 108(2022)Supplement 2
- Journal:
- Heart
- Issue:
- Volume 108(2022)Supplement 2
- Issue Display:
- Volume 108, Issue 2 (2022)
- Year:
- 2022
- Volume:
- 108
- Issue:
- 2
- Issue Sort Value:
- 2022-0108-0002-0000
- Page Start:
- A6
- Page End:
- A6
- Publication Date:
- 2022-09-21
- Subjects:
- Heart -- Diseases -- Treatment -- Periodicals
Cardiology -- Periodicals
616.12 - Journal URLs:
- http://www.bmj.com/archive ↗
http://heart.bmj.com ↗
http://www.heartjnl.com ↗ - DOI:
- 10.1136/heartjnl-2022-BSCI.14 ↗
- Languages:
- English
- ISSNs:
- 1355-6037
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24103.xml